Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,534.68
(
-1.09%
)
US TECH 100
23,397.00
(
-1.37%
)
Dow Jones
45,756.66
(
-0.58%
)
Brent Oil
107.39
(
2.83%
)
Bitcoin
69,574.00
(
-0.46%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 150873

Tuesday, 11/27/2012 9:05:01 AM

Tuesday, November 27, 2012 9:05:01 AM

Post# of 257262
BCRX’s BCX4161 is now on FDA clinical hold:

http://www.sec.gov/Archives/edgar/data/882796/000119312512480941/d444881d8k.htm

The FDA will provide a letter within 30 days outlining the reasons for the clinical hold and the information required to have the hold removed. The Company had previously guided the initiation of Phase 1 testing in the United States before the end of 2012. The Company now estimates that Phase 1 testing of BCX4161 will be delayed approximately three months.

What a debacle the BCRX-Presidio merger has become.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today